Twinbeech Capital LP Xencor Inc Transaction History
Twinbeech Capital LP
- $4.99 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding XNCR
# of Institutions
214Shares Held
71.8MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$203 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$167 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.6MShares$139 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$97.4 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$71.8 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.09B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...